Search Results

Displaying Results 1776-1800 of 8367 "'BODY'"

Jun 29, 2026, 04:47 ET Ever Supreme Launches Phase IIa Clinical Trial for CAR001, Accelerating Global Market Expansion

preparatory chemo was required to clear out immune-suppressing cells, keep the introduced CAR-T cells from being accidentally destroyed by the patient's own body, and boost their survival rate. However, this chemo comes at a heavy cost, significantly increasing the patient's risk of infection and causing side

More news about: Ever Supreme Bio Technology Co., Ltd.


Jun 29, 2026, 03:58 ET Positive interim analysis advances Avecho Phase III insomnia program

the pivotal Phase III clinical trial. The DMB is comprised of independent experts in sleep medicine, clinical safety and biostatistics and is the only body with access to unblinded trial data.The DMB has unanimously recommended the trial continue to the full planned enrolment of 519 participants.

More news about: Avecho Biotechnology Limited


Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

(AA) is an unpredictable autoimmune disease causing a range of hair loss patterns, from sudden, round bald patches on the scalp to complete loss of all body hair, including scalp, face, eyebrows and eyelashes.3,4 Despite its immune-mediated nature, AA is often considered a cosmetic problem, which

More news about: AbbVie


Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

(AA) is an unpredictable autoimmune disease causing a range of hair loss patterns, from sudden, round bald patches on the scalp to complete loss of all body hair, including scalp, face, eyebrows and eyelashes.3,4 Despite its immune-mediated nature, AA is often considered a cosmetic problem, which

More news about: AbbVie


Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo

from the Phase 3 Viti-Up clinical studies, in which upadacitinib achieved both co-primary endpoints demonstrating at least a 50% improvement in total body repigmentation (T-VASI 50) and at least a 75% improvement in facial repigmentation (F-VASI 75) from baseline at week 481

More news about: AbbVie


Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo

from the Phase 3 Viti-Up clinical studies, in which upadacitinib achieved both co-primary endpoints demonstrating at least a 50% improvement in total body repigmentation (T-VASI 50) and at least a 75% improvement in facial repigmentation (F-VASI 75) from baseline at week 481

More news about: AbbVie


Jun 28, 2026, 23:09 ET Remplir™: Australian Nerve Repair Device Supports Victims of War in Ukraine

management," said Mr Anderson.Remplir is redefining the global standard of care for nerve repair procedures, by unlocking the power of the human body to heal. Remplir is made from pure collagen (acellular, type 1) and in clinical practice creates a bioactive healing chamber to support new tissue formation

More news about: Orthocell Ltd


Jun 28, 2026, 16:55 ET Sunaofe Announces Pre-Order for the Atlas Ergonomic Office Chair: Redefining Premium Workspace Support

permanent lifestyle, millions of professionals are realizing the physical toll of inadequate seating. Traditional office chairs remain static, but the human body does not. The Sunaofe Atlas was designed to solve this exact problem by introducing an intuitive, continuous support system.

More news about: SUNON(S) PTE. LTD.


Jun 28, 2026, 16:00 ET Monster Energy Riders Claim Key Victories on Day 2 of X Games Sacramento 2026

opposite stance, to claim her second gold medal at X Games Sacramento 2026. Trew also came close to landing an NBD trick before the time ran out: a switch body varial McTwist stoked the crowd and judges and showed Trew's innovative potential once again.On the strength of her gold medal, Trew now matches

More news about: Monster Energy


Jun 28, 2026, 11:26 ET WISEcode® Sets Out to Transform the Food Industry, Ushering In the Era of FoodTruth™

Artificial Intelligence, paired with food data, deeply removes that barrier. When every shopper can know what is in a product and what it does to their body, competition shifts from perception to performance, and the advantage moves to the companies with the best products rather than the biggest budgets."AI

More news about: WISEcode


Jun 28, 2026, 06:02 ET AGIBOT's 15,000th Robot Rolls Off the Production Line, Marking a New Milestone in Embodied AI Deployment

deployment.Embodied AI robots are not simply hardware products. Bringing them from production to real-world use requires integrated capabilities across robot body design, full-system manufacturing, software-hardware integration, application-specific adaptation, and implementation in the field. Sustained production

More news about: AgiBot Innovation (Shanghai) Technology Co.,Ltd.


Jun 27, 2026, 11:00 ET What Consumers Should Know About Supplements for Vein Health Featuring Horse Chestnut and Butcher's Broom, According to PureHealth Research

Vein Function and Vascular WellnessVeins carry blood back to the heart, making them essential to healthy circulation throughout the body. Supporting healthy vein structure and vascular function may contribute to everyday comfort and mobility as part of a broader wellness routine.Horse

More news about: PureHealth Research LLC


Jun 26, 2026, 17:07 ET NACCHO Announces Its 2026-2027 Board of Directors

vision."NACCHO is governed by a 20-member board comprising local and tribal health officials who are elected by their peers. As the governing body, NACCHO's Board of Directors establishes the association's strategic direction and initiatives, sets the annual legislative agenda, approves official

More news about: NACCHO (National Association of County & City Health Officials)


Jun 26, 2026, 16:50 ET SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

warm, red, or painful skin or sores on your body different from your psoriasisweight loss

More news about: AbbVie


Jun 26, 2026, 16:43 ET NACCHO Announces Dr. Patrick McGough as its 2026-2027 Board President

MNNACCHO is governed by a 20-member board comprising local and tribal health officials who are elected by their peers. As the governing body, NACCHO's Board of Directors establishes the association's strategic direction and initiatives, sets the annual legislative agenda, approves official

More news about: NACCHO (National Association of County & City Health Officials)


Jun 26, 2026, 16:00 ET Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)

arthritis with more than 12 million people in the United States having been diagnosed.[1] Gout is caused by high levels of uric acid in the body that accumulate around the joints and other tissues and can result in flares that cause intense pain.[2] Approximately 200,000 people in

More news about: Swedish Orphan Biovitrum AB


Jun 26, 2026, 15:59 ET Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)

arthritis with more than 12 million people in the United States having been diagnosed.[1] Gout is caused by high levels of uric acid in the body that accumulate around the joints and other tissues and can result in flares that cause intense pain.[2] Approximately 200,000 people in

More news about: Swedish Orphan Biovitrum AB


Jun 26, 2026, 14:12 ET The CABEI Board of Governors marks a milestone with the approval of a new US$3 billion capital increase and the strengthening of the Bank's governance

Spain, June 26, 2026 /PRNewswire/ -- The CABEI Board of Governors, the institution's highest governing body, today approved several strategic decisions to strengthen the Bank's governance, financial soundness, and relevance, marking one of the most important

More news about: CABEI


Jun 26, 2026, 12:35 ET Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

journey," said Carlo Antozzi, M.D., Neurological Institute Foundation C. Besta of Milan, Italy.d "These post-hoc analyses add to the growing body of evidence on IMAAVY, which is designed to selectively target and bind the neonatal Fc receptor with high affinity, and reduce pathogenic immunoglobulin

More news about: Johnson & Johnson


Jun 26, 2026, 12:04 ET Pediatric Occupational Therapy Expert Kathy Schleifer of Pueblo Explains Sensory Integration Therapy for HelloNation

individualized plans that include fun, movement-based activities such as swinging, climbing, or using textured materials. These experiences encourage the body and brain to communicate more efficiently, reducing discomfort and improving attention, coordination, and emotional regulation.Sensory integration

More news about: HelloNation


Jun 26, 2026, 10:17 ET Group 1 Automotive Announces the Toyota Certified at Capital Plaza Collision Center is now Group 1 Toyota Capital Plaza Collision

Certified Capital Plaza, supporting drivers throughout Landover Hills, Hyattsville, Bladensburg, and surrounding Maryland communities with collision repair, body work, paint and refinishing, and post-repair support for Toyota vehicles and other makes.The collision center remains focused on the same local

More news about: Group 1 Automotive, Inc.


Jun 26, 2026, 10:00 ET 2026 John Cotton Dana Awards Celebrate 80 Years of Recognizing Excellence in Library Marketing and Communications

1957, The H.W. Wilson Foundation has focused on providing financial assistance to causes having the greatest impact on improving the spirit, mind and body of the greatest number of people through aid, support and cooperation with charitable, benevolent, educational and religious institutions. Major donors

More news about: EBSCO Information Services


Jun 26, 2026, 09:05 ET Servier Presentations at ISPNO 2026 Highlight Neuro-Oncology Leadership and Expanding Glioma Portfolio

"Our upcoming presentations at ISPNO 2026 help strengthen the robust body of evidence supporting the safety and efficacy of OJEMDA, further establishing it as a standard of care for children with relapsed/refractory pediatric

More news about: Servier Pharmaceuticals


Jun 26, 2026, 09:00 ET Korean Skincare Brand Meditherapy Tops Amazon U.S. Facial Serums, Breaking Into Beauty Best Sellers Top 20

improvements in skin texture" and a "gentle, non-irritating feel" even for sensitive skin types. Its unique versatility — suitable for both the face and body — has also resonated strongly with consumers seeking high-performance, multi-purpose solutions.A Sustainable Growth ModelUnlike

More news about: Meditherapy


Jun 26, 2026, 09:00 ET Life Time Brings 16th Location in Chicago with Opening of Life Time North Shore, Featuring 28 Pickleball Courts

feature a steam room, sauna, cold plunge and whirlpool, while the currently open LT Recovery space features water massage and cold therapy chairs, whole-body compression technology, percussion devices, metabolic testing and nutrition coaching. In warmer months, members can unwind at the outdoor Beach Club,

More news about: Life Time, Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.